SCHEMBL4048413

SCHEMBL4048413

COc1ccccc1Nc1nc(N(C(=O)OC(C)(C)C)C2CCNC2)nc(C(=O)O)c1N

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 5/20 0.35
SLC6A4 P31645 5/20 0.35
SLC6A3 Q01959 4/20 0.35
CYP2D6 P10635 3/20 0.35
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
KCNH2 Q12809 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
ALDH1A1 P00352 2/20 0.34
POLB P06746 1/20 0.34
HSD17B10 Q99714 1/20 0.34
HTR2A P28223 1/20 0.34
MBTPS1 Q14703 1/20 0.34
TYK2 P29597 2/20 0.33
JAK2 O60674 1/20 0.33
JAK1 P23458 1/20 0.33
JAK3 P52333 1/20 0.33
MAPT P10636 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4048341 0.88 MAPT (0.40) SLC6A2SLC6A4SLC6A3CYP2D6KMT2A
SCHEMBL4050683 0.77 KDM4E (0.43) SLC6A2SLC6A4SLC6A3CYP2D6KMT2A
SCHEMBL4232406 0.74 KMT2A (0.37) KMT2AMEN1SMN1; SMN2ALDH1A1HSD17B10
SCHEMBL1752661 0.69 BTK (0.46) ALDH1A1
SCHEMBL4232401 0.69 TRPV1 (0.42) KMT2AMEN1ALDH1A1HSD17B10MAPT
SCHEMBL529996 0.68 SLC6A4 (0.36) SLC6A2SLC6A4SLC6A3CYP2D6KCNH2
SCHEMBL28329578 0.66 SLC6A4 (0.39) SLC6A2SLC6A4SLC6A3CYP2D6KCNH2
SCHEMBL3662458 0.65 SLC6A4 (0.42) SLC6A2SLC6A4SLC6A3CYP2D6KCNH2
SCHEMBL9085375 0.64 SLC6A2 (0.48) SLC6A2SLC6A4SLC6A3CYP2D6KMT2A
SCHEMBL9905303 0.64 SLC6A2 (0.48) SLC6A2SLC6A4SLC6A3CYP2D6KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2078018-A1 HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND USE THEREOF AS PROTEIN KINASE INHIBITORS Signal Pharmaceuticals LLC (US) 2009-07-15 EP disclosed
WO-2008051494-A1 HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND USE THEREOF AS PROTEIN KINASE INHIBITORS SIGNAL PHARMACEUTICALS, LLC (US) 2008-05-02 WO disclosed